CIA
RMD icon

Capital Impact Advisors’s ResMed RMD Stock Holding History

Capital Impact Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.54M Sell
38,046
-121,312
-76% -$30.2M 3.45% 9
2025
Q4 		$38.4M Buy
159,358
+114,318
+254% +$29.2M 3% 15
2025
Q3 		$12.3M Buy
45,040
+8,173
+22% +$2.23M 2.76% 17
2025
Q2 		$9.61M Sell
36,867
-1,272
-3% -$303K 2.89% 14
2025
Q1 		$8.54M Buy
+38,139
New +$8.9M 3.27% 13
2023
Q1 		– Sell
-1,916
Closed -$399K – 223
2022
Q4 		$399K Buy
1,916
+56
+3% +$12.3K 0.39% 110
2022
Q3 		$406K Sell
1,860
-536
-22% -$122K 0.4% 102
2022
Q2 		$502K Sell
2,396
-1,096
-31% -$233K 0.46% 94
2022
Q1 		$847K Sell
3,492
-1,956
-36% -$473K 0.62% 62
2021
Q4 		$1.42M Hold
5,448
– – 0.98% 38
2021
Q3 		$1.44M Buy
+5,448
New +$1.49M 0.57% 76
2021
Q1 		– Sell
-16,125
Closed -$3.43M – 130
2020
Q4 		$3.43M Hold
16,125
– – 0.84% 50
2020
Q3 		$2.76M Hold
16,125
– – 0.82% 54
2020
Q2 		$3.1M Hold
16,125
– – 1.03% 27
2020
Q1 		$2.38M Buy
+16,125
New +$2.57M 1% 31
2016
Q2 		– Sell
-22,484
Closed -$1.3M – 233
2016
Q1 		$1.3M Buy
22,484
+984
+5% +$55.7K 0.62% 31
2015
Q4 		$1.15M Buy
+21,500
New +$1.21M 0.55% 44

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Impact Advisors's RMD Position: Q1 2026 in Review

Capital Impact Advisors reduced its ResMed (RMD) stake by 76% in Q1 2026, selling an estimated $30.2M and leaving 38,046 shares worth $8.54M. The position accounts for 3.45% of the portfolio, ranked #9.

Capital Impact Advisors first reported a position in RMD in Q4 2015 and has held it in 17 quarters since. The position peaked at $38.4M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Capital Impact Advisors held 38,046 shares of ResMed worth $8.54M as of Q1 2026.
  • Capital Impact Advisors sold 121,312 ResMed shares in Q1 2026, an estimated $30.2M.
  • ResMed made up 3.45% of Capital Impact Advisors's portfolio in Q1 2026, its #9 holding.
  • Capital Impact Advisors first reported a position in ResMed in Q4 2015 and has held it in 17 quarters since.
  • Capital Impact Advisors's ResMed position peaked at $38.4M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Capital Impact Advisors's 13F filing for Q1 2026, filed 15 May 2026.